phenyl acetate has been researched along with Cardiometabolic Syndrome in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Guo, J; Huang, K; Kang, SG; Li, M; Tong, T; Zhao, Y | 1 |
Abdelrahman, AM; Abdelzaher, WY; Amin, EF; Ibrahim, MA; Ibrahim, SA | 1 |
Costabile, G; Giacco, R; Luongo, D; Naviglio, D; Riccardi, G; Rivellese, AA; Vetrani, C | 1 |
Trajkovski, M; Wollheim, CB | 1 |
Barry, NA; Cardone, RL; Cline, GW; Goodman, AL; Kibbey, RG; Peng, L; Perry, RJ; Petersen, KF; Shulman, GI; Zhang, D | 1 |
Ballerini, A; Filgueira, CS; Fraga, D; Gaber, AO; Garcia-Huidobro, J; Grattoni, A; Hood, RL; Lin, JZ; Nicolov, E; Phillips, KJ; Sabek, OM; Webb, P | 1 |
Abo-Youssef, AM; Osman, AH; Owis, AI | 1 |
Charytan, D; Di Carli, MF; Dorbala, S; Ganz, P; McMahon, GT; Schelbert, HR | 1 |
Ernsberger, P; Friedman, JE; Shao, J; Velliquette, RA; Zhang, BB | 1 |
Ala-Korpela, M; Forsblom, C; Groop, PH; Ingman, P; Kaski, K; Mäkinen, VP; Parkkonen, M; Soininen, P | 1 |
2 trial(s) available for phenyl acetate and Cardiometabolic Syndrome
Article | Year |
---|---|
Effects of whole-grain cereal foods on plasma short chain fatty acid concentrations in individuals with the metabolic syndrome.
Topics: Acetates; Biomarkers; Blood Glucose; Body Mass Index; Butyrates; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Diet; Dietary Fiber; Energy Intake; Fatty Acids, Volatile; Female; Humans; Insulin; Interleukin-1alpha; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Obesity; Overweight; Patient Compliance; Postprandial Period; Propionates; Triglycerides; Tumor Necrosis Factor-alpha; Whole Grains | 2016 |
Coronary circulatory function in patients with the metabolic syndrome.
Topics: Acetamides; Acetates; Adenosine; Adolescent; Adult; Aged; Anticholesteremic Agents; Body Mass Index; C-Reactive Protein; Cholesterol; Cohort Studies; Coronary Artery Disease; Coronary Circulation; Data Interpretation, Statistical; Double-Blind Method; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Positron-Emission Tomography; Risk Factors; Sulfonamides; Sulfonic Acids; Vascular Resistance; Vasodilator Agents; Young Adult | 2011 |
8 other study(ies) available for phenyl acetate and Cardiometabolic Syndrome
Article | Year |
---|---|
Dietary Supplementation of Cedryl Acetate Ameliorates Adiposity and Improves Glucose Homeostasis in High-Fat Diet-Fed Mice.
Topics: Acetates; Adiposity; Animals; Diet, High-Fat; Dietary Supplements; Glucose; Homeostasis; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; RNA, Ribosomal, 16S | 2023 |
Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats.
Topics: Acetates; Alanine Transaminase; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Glucose; Caspase 3; Cyclopropanes; Fructose; Insulin; Irbesartan; Leukotriene Antagonists; Lipids; Liver; Liver Diseases; Male; Metabolic Syndrome; Quinolines; Rats; Rats, Wistar; Sulfides; Tetrazoles | 2014 |
Physiology: Microbial signals to the brain control weight.
Topics: Acetates; Animals; Brain; Gastrointestinal Microbiome; Insulin-Secreting Cells; Metabolic Syndrome | 2016 |
Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome.
Topics: Acetates; Animals; Brain; Diet, High-Fat; Gastrointestinal Microbiome; Ghrelin; Glucose; Hyperphagia; Insulin; Insulin Secretion; Insulin-Secreting Cells; Metabolic Syndrome; Obesity; Parasympathetic Nervous System; Rats | 2016 |
Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome.
Topics: Acetates; Animals; Diet, High-Fat; Disease Models, Animal; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Obese; Molecular Targeted Therapy; Obesity; Phenols; Thyroid Hormone Receptors beta | 2016 |
Leaves of Cordia boissieri A. DC. as a potential source of bioactive secondary metabolites for protection against metabolic syndrome-induced in rats.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Antioxidants; Cordia; Flavonols; Food, Formulated; Fructose; Hypoglycemic Agents; Kaempferols; Male; Metabolic Syndrome; Oxidative Stress; Plant Extracts; Plant Leaves; Quercetin; Rats; Rats, Wistar; Secondary Metabolism; Solvents; Structure-Activity Relationship | 2017 |
Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X.
Topics: Acetates; Adipose Tissue; Animals; Blood Pressure; Body Weight; Eating; Female; Glucose Tolerance Test; Hyperinsulinism; Indoles; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Obesity; Phosphatidylinositol 3-Kinases; Phosphoproteins; PPAR gamma; Rats; Rats, Inbred SHR; Receptor, Insulin; Signal Transduction | 2005 |
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death.
Topics: Acetates; Adult; Albuminuria; Antihypertensive Agents; Apolipoproteins B; Biomarkers; Cholesterol; Cholesterol, HDL; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lactic Acid; Metabolic Syndrome; Middle Aged; Nuclear Magnetic Resonance, Biomolecular; Protons; Reproducibility of Results; Triglycerides; Urea | 2008 |